Medtronic Derivative liabilities increased by 304.2% to $97.00M in Q1 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in derivative liabilities often signals adverse market movements against the company's hedging positions or an increase in hedging activity.
This represents the aggregate fair value of all derivative financial instruments that are currently in a net loss positi...
Highly comparable across multinational peers that utilize derivatives to manage global currency and interest rate exposures.
fin_derivative_liabilities| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q2 '24 | Q4 '25 | |
|---|---|---|---|---|---|---|
| Value | $61.00M | $20.00M | $20.00M | $18.00M | $24.00M | $97.00M |
| QoQ Change | — | -67.2% | +0.0% | -10.0% | +33.3% | +304.2% |
| YoY Change | — | — | — | — | +33.3% | — |